Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Post-Punch Biopsy Bleeding with BXP154
NCT05837338Phase 2Completed
- Sponsor
- Bio 54
- Start
- May 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BXP-154 in wound hemorrhage, sponsored by Bio 54. Started May 2023; status: completed.
02
Drugs
BXP-154
03
Conditions
wound hemorrhage
Beyond the preview
Go deeper on NCT05837338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05837338.